Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Am J Med Sci (1969) 257:4159.10.1097/00000441-196906000-00008 163 SenerALebrunPBlachierFMalaisseWJ
Editors Note: An earlier version of this story said that Lilly expects to file orforglipron to the FDA in the new year
Notable Investors: Alkeon Capital Management, Capital 7, DST Global, Thrive Capital, Endurance Global Ventures, Evolution VC Partners, Nvidia, Google Ventures, Sequoia, Kleiner Perkins Key Products: OpenEvidence is an AI copilot for healthcare providers that helps them make high-stakes decisions at the point of care
Some patients achieve satisfactory weight loss at intermediate doses (1.0 or 1.7 mg) and may not need to escalate to the full 2.4 mg dose
Separately, a Trustpilot profile for viviomd.com shows a TrustScore around 3.1 out of 5 on a small number of reviews as of July 2026 - worth checking directly, since a small sample can shift quickly
US$ 21.74
US$ 22.42
US$ 23.98
US$ 28.16
,aspect=ignore)
